Pseudotype-independent nonspecific uptake of gammaretroviral and lentiviral particles in human cells

Human Gene Therapy

Volumn 23, Issue 3, 2012, Pages 274-286

  Voelkel, Christine ^a   Galla, Melanie ^a   Dannhauser, Philip N ^a   Maetzig, Tobias ^a   Sodeik, Beate ^a   Schambach, Axel ^a   Baum, Christopher ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BAFILOMYCIN A1; CHLOROQUINE; GAG PROTEIN; GREEN FLUORESCENT PROTEIN; LENTIVIRUS VECTOR; MESSENGER RNA; RETROVIRUS VECTOR; VIRUS ENVELOPE PROTEIN;

ARTICLE; CELL LINE; CONTROLLED STUDY; CYTOSOL; DEGRADATION; ECOTROPIC VIRUS; ENDOCYTOSIS; ENDOSOME; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; LYSOSOME; MEASLES VIRUS; MURINE LEUKEMIA VIRUS; PROTEIN SECRETION; PROTEIN TRANSPORT; PSEUDOTYPING; T LYMPHOCYTE; VIRAL GENE DELIVERY SYSTEM; VIRUS ENTRY; VIRUS PARTICLE;

CELL LINE; ENDOCYTOSIS; ENDOSOMES; GENE PRODUCTS, GAG; GENETIC VECTORS; GREEN FLUORESCENT PROTEINS; HIV-1; HUMANS; KINETICS; MOLONEY MURINE LEUKEMIA VIRUS; TRANSDUCTION, GENETIC; VIRAL ENVELOPE PROTEINS; VIRION; VIRUS ASSEMBLY;

HUMAN IMMUNODEFICIENCY VIRUS 1; MEASLES VIRUS; MURINAE; MURINE LEUKEMIA VIRUS;

EID: 84858052754     PISSN: 10430342     EISSN: 15577422     Source Type: Journal    
DOI: 10.1089/hum.2011.011     Document Type: Article

References (74)

1. Ahle, S., Mann, A., Eichelsbacher, U., and Ungewickell, E. (1988). Structural relationships between clathrin assembly proteins from the Golgi and the plasma membrane. EMBO J. 7, 919-929.
2. Albritton, L.M., Tseng, L., Scadden, D., and Cunningham, J.M. (1989). A putative murine ecotropic retrovirus receptor gene encodes a multiple membrane-spanning protein and confers susceptibility to virus infection. Cell 57, 659-666. (Pubitemid 19140646)
3. Albritton, L.M., Kim, J.W., Tseng, L., and Cunningham, J.M. (1993). Envelope-binding domain in the cationic amino acidtransporter determines the host range of ecotropic murine retroviruses. J. Virol. 67, 2091-2096. (Pubitemid 23088383)
4. Alvarez Losada, S., Canto-Nogues, C., and Munoz-Fernandez, M.A. (2002). A new possible mechanism of human immunodeficiency virus type 1 infection of neural cells. Neurobiol. Dis. 11, 469-478. (Pubitemid 36269131)
5. Andersen, K.B., and Nexo, B.A. (1983). Entry of murine retrovirus into mouse fibroblasts. Virology 125, 85-98. (Pubitemid 13149565)
6. Benedict, C.A., Tun, R.Y., Rubinstein, D.B., et al. (1999). Targeting retroviral vectors to CD34-expressing cells: Binding to CD34 does not catalyze virus-cell fusion. Hum. Gene Ther. 10, 545-557. (Pubitemid 29131321)
7. Botos, E., Klumperman, J., Oorschot, V., et al. (2008). Caveolin-1 is transported to multi-vesicular bodies after albumin-induced endocytosis of caveolae in HepG2 cells. J. Cell. Mol. Med. 12, 1632-1639.
8. Boztug, K., Dewey, R.A., and Klein, C. (2006). Development of hematopoietic stem cell gene therapy for Wiskott-Aldrich syndrome. Curr. Opin. Mol. Ther. 8, 390-395. (Pubitemid 44566780)
9. Buchholz, C.J., Muhlebach, M.D., and Cichutek, K. (2009). Lentiviral vectors with measles virus glycoproteins: Dream team for gene transfer? Trends Biotechnol. 27, 259-265.
10. Cappelli, B., and Aiuti, A. (2010). Gene therapy for adenosine deaminase deficiency. Immunol. Allergy Clin. North Am. 30, 249-260.
11. Daecke, J., Fackler, O.T., Dittmar, M.T., and Krausslich, H.G. (2005). Involvement of clathrin-mediated endocytosis in human immunodeficiency virus type 1 entry. J. Virol. 79, 1581-1594. (Pubitemid 40459105)
12. Dalba, C., Bellier, B., Kasahara, N., and Klatzmann, D. (2007). Replication-competent vectors and empty virus-like particles: New retroviral vector designs for cancer gene therapy or vaccines. Mol. Ther. 15, 457-466.
13. Fehse, B., Richters, A., Putimtseva-Scharf, K., et al. (2000). CD34 splice variant: An attractive marker for selection of genemodified cells. Mol. Ther. 1, 448-456.
14. Frecha, C., Costa, C., Negre, D., et al. (2008). Stable transduction of quiescent T-cells without induction of cycle progression by a novel lentiviral vector pseudotyped with measles virus glycoproteins. Blood 112, 4843-4852.
15. Frecha, C., Costa, C., Levy, C., et al. (2009). Efficient and stable transduction of resting B lymphocytes and primary chronic lymphocyte leukemia cells using measles virus GP displaying lentiviral vectors. Blood 114, 3173-3180.
16. Fredericksen, B.L., Wei, B.L., Yao, J., et al. (2002). Inhibition of endosomal/lysosomal degradation increases the infectivity of human immunodeficiency virus. J. Virol. 76, 11440-11446. (Pubitemid 35231300)
17. Freundt, E.C., Czapiga, M., and Lenardo, M.J. (2007). Photoconversion of LysoTracker red to a green fluorescent molecule. Cell Res. 17, 956-958. (Pubitemid 350126866)
18. Funke, S., Maisner, A., Muhlebach, M.D., et al. (2008). Targeted cell entry of lentiviral vectors. Mol. Ther. 16, 1427-1436.
19. Galla, M., Will, E., Kraunus, J., et al. (2004). Retroviral pseudotransduction for targeted cellmanipulation. Mol. Cell 16, 309-315.
20. Galla, M., Schambach, A., Towers, G.J., and Baum, C. (2008). Cellular restriction of retrovirus particle-mediated mRNA transfer. J. Virol. 82, 3069-3077. (Pubitemid 351329195)
21. Ghosh, P., and Kornfeld, S. (2004). The GGA proteins: key players in protein sorting at the trans-Golgi network. Eur. J. Cell Biol. 83, 257-262. (Pubitemid 39307163)
22. Ginsburg, H. (1990). Antimalarial drugs: is the lysosomotropic hypothesis still valid? Parasitol. Today 6, 334-337.
23. Hacein-Bey-Abina, S., Hauer, J., Lim, A., et al. (2010). Efficacy of gene therapy for X-linked severe combined immunodeficiency. N. Engl. J. Med. 363, 355-364.
24. Hayer, A., Stoeber, M., Ritz, D., et al. (2010). Caveolin-1 is ubiquitinated and targeted to intralumenal vesicles in endolysosomes for degradation. J. Cell Biol. 191, 615-629.
25. Hewlett, L.J., Prescott, A.R., and Watts, C. (1994). The coated pit and macropinocytic pathways serve distinct endosome populations. J. Cell Biol. 124, 689-703. (Pubitemid 24085779)
26. Hildinger, M., Abel, K.L., Ostertag, W., and Baum, C. (1999). Design of 5¢ untranslated sequences in retroviral vectors developed for medical use. J. Virol. 73, 4083-4089. (Pubitemid 29189853)
27. Jinno-Oue, A.,Oue,M., andRuscetti, S.K. (2001).Aunique heparinbinding domain in the envelope protein of the neuropathogenic PVC-211 murine leukemia virus may contribute to its brain capillary endothelial cell tropism. J. Virol. 75, 12439-12445. (Pubitemid 33115916)
28. Kang, E.M., Choi, U., Theobald, N., et al. (2010). Retrovirus gene therapy for X-linked chronic granulomatous disease can achieve stable long-term correction of oxidase activity in peripheral blood neutrophils. Blood 115, 783-791.
29. Katen, L.J., Januszeski, M.M., Anderson, W.F., et al. (2001). Infectious entry by amphotropic as well as ecotropic murine leukemia viruses occurs through an endocytic pathway. J. Virol. 75, 5018-5026. (Pubitemid 32448522)
30. Kim, J.W., Closs, E.I., Albritton, L.M., and Cunningham, J.M. (1991). Transport of cationic amino acids by the mouse ecotropic retrovirus receptor. Nature 352, 725-728. (Pubitemid 21912417)
31. Kiss, A.L., and Botos, E. (2009). Endocytosis via caveolae: Alternative pathway with distinct cellular compartments to avoid lysosomal degradation? J. Cell. Mol. Med. 13, 1228-1237.
32. Kizhatil, K., and Albritton, L.M. (1997). Requirements for different components of the host cell cytoskeleton distinguish ecotropic murine leukemia virus entry via endocytosis from entry via surface fusion. J. Virol. 71, 7145-7156. (Pubitemid 27391648)
33. Koch, P., Lampe, M., Godinez, W.J., et al. (2009). Visualizing fusion of pseudotyped HIV-1 particles in real time by live cell microscopy. Retrovirology 6, 84.
34. Kreppel, F., Gackowski, J., Schmidt, E., and Kochanek, S. (2005). Combined genetic and chemical capsid modifications enable flexible and efficient de-and retargeting of adenovirus vectors. Mol. Ther. 12, 107-117. (Pubitemid 40862362)
35. Lakadamyali, M., Rust, M.J., and Zhuang, X. (2004). Endocytosis of influenza viruses. Microbes Infect. 6, 929-936. (Pubitemid 39061215)
36. Lorimer, I.A., and Lavictoire, S.J. (2000). Targeting retrovirus to cancer cells expressing a mutant EGF receptor by insertion of a single chain antibody variable domain in the envelope glycoprotein receptor binding lobe. J. Immunol. Methods 237, 147-157. (Pubitemid 30139510)
37. Lu, X., and Silver, J. (2000). Ecotropic murine leukemia virus receptor is physically associated with caveolin and membrane rafts. Virology 276, 251-258.
38. Maeda, T., Kawasaki, K., and Ohnishi, S. (1981). Interaction of influenza virus hemagglutinin with target membrane lipids is a key step in virus-induced hemolysis and fusion at pH 5.2. Proc. Natl. Acad. Sci. U.S.A. 78, 4133-4137. (Pubitemid 11010298)
39. Marechal, V., Clavel, F., Heard, J.M., and Schwartz, O. (1998). Cytosolic Gag p24 as an index of productive entry of human immunodeficiency virus type 1. J. Virol. 72, 2208-2212. (Pubitemid 28100778)
40. Maurer, U.E., Sodeik, B., and Grunewald, K. (2008). Native 3D intermediates of membrane fusion in herpes simplex virus 1 entry. Proc. Natl. Acad. Sci. U.S.A. 105, 10559-10564.
41. McClure, M.O., Marsh, M., and Weiss, R.A. (1988). Human immunodeficiency virus infection of CD4-bearing cells occurs by a pH-independent mechanism. EMBO J. 7, 513-518.
42. McClure, M.O., Sommerfelt, M.A., Marsh, M., and Weiss, R.A. (1990). The pH independence of mammalian retrovirus infection. J. Gen. Virol. 71, 767-773. (Pubitemid 20132879)
43. Mercer, J., and Helenius, A. (2009). Virus entry by macropinocytosis. Nat. Cell Biol. 11, 510-520.
44. Mercer, J., Schelhaas, M., and Helenius, A. (2010). Virus entry by endocytosis. Annu. Rev. Biochem. 79, 803-833.
45. Mikulak, J., and Singhal, P.C (2010). HIV-1 and kidney cells: Better understanding of viral interaction. Nephron Exp. Nephrol. 115, e15-e21.
46. Miyauchi, K., Kim, Y., Latinovic, O., et al. (2009). HIV enters cells via endocytosis and dynamin-dependent fusion with endosomes. Cell 137, 433-444.
47. Mondor, I., Ugolini, S., and Sattentau, Q.J. (1998). Human immunodeficiency virus type 1 attachment to HeLa CD4 cells is CD4 independent and gp120 dependent and requires cell surface heparans. J. Virol. 72, 3623-3634. (Pubitemid 28188659)
48. Morita, S., Kojima, T., and Kitamura, T. (2000). Plat-E: An efficient and stable system for transient packaging of retroviruses. Gene Ther. 7, 1063-1070.
49. Mu, F.T., Callaghan, J.M., Steele-Mortimer, O., et al. (1995). EEA1, an early endosome-associated protein: EEA1 is a conserved a-helical peripheral membrane protein flanked by cysteine "fingers" and contains a calmodulin-binding IQ motif. J. Biol. Chem. 270, 13503-13511.
50. Muller, B., Daecke, J., Fackler, O.T., et al. (2004). Construction and characterization of a fluorescently labeled infectious human immunodeficiency virus type 1 derivative. J. Virol. 78, 10803-10813. (Pubitemid 39258405)
51. Pizzato, M., Marlow, S.A., Blair, E.D., and Takeuchi, Y. (1999). Initial binding of murine leukemia virus particles to cells does not require specific Env-receptor interaction. J. Virol. 73, 8599-8611. (Pubitemid 29441724)
52. Pizzato, M., Blair, E.D., Fling, M., et al. (2001). Evidence for nonspecific adsorption of targeted retrovirus vector particles to cells. Gene Ther. 8, 1088-1096. (Pubitemid 32962706)
53. Ragheb, J.A., and Anderson, W.F. (1994). pH-independent murine leukemia virus ecotropic envelope-mediated cell fusion: implications for the role of the R peptide and p12E TM in viral entry. J. Virol. 68, 3220-3231. (Pubitemid 24129772)
54. Risco, C., Menendez-Arias, L., Copeland, T.D., et al. (1995). Intracellular transport of the murine leukemia virus during acute infection of NIH 3T3 cells: nuclear import of nucleocapsid protein and integrase. J. Cell Sci. 108, 3039-3050.
55. Schaeffer, E., Geleziunas, R., and Greene, W.C. (2001). Human immunodeficiency virus type 1 Nef functions at the level of virus entry by enhancing cytoplasmic delivery of virions. J. Virol. 75, 2993-3000. (Pubitemid 32185064)
56. Schambach, A., Wodrich, H., Hildinger, M., et al. (2000). Context dependence of different modules for posttranscriptional enhancement of gene expression from retroviral vectors. Mol. Ther. 2, 435-445.
57. Schambach, A., Bohne, J., Chandra, S., et al. (2006a). Equal potency of gammaretroviral and lentiviral SIN vectors for expression of O6-methylguanine-DNA methyltransferase in hematopoietic cells. Mol. Ther. 13, 391-400. (Pubitemid 43056905)
58. Schambach, A., Galla, M., Modlich, U., et al. (2006b). Lentiviral vectors pseudotyped with murine ecotropic envelope: Increased biosafety and convenience in preclinical research. Exp. Hematol. 34, 588-592.
59. Schambach, A., Mueller, D., Galla, M., et al. (2006c). Overcoming promoter competition in packaging cells improves production of self-inactivating retroviral vectors. Gene Ther. 13, 1524-1533. (Pubitemid 44567149)
60. Schott, J.W., Galla, M., Godinho, T., et al. (2011). Viral and nonviral approaches for transient delivery of mRNA and protein. Curr. Gene Ther. 11, 382-398.
61. Sharma, S., Murai, F., Miyanohara, A., and Friedmann, T. (1997). Noninfectious virus-like particles produced by Moloney murine leukemia virus-based retrovirus packaging cells deficient in viral envelope become infectious in the presence of lipofection reagents. Proc. Natl. Acad. Sci. U.S.A. 94, 10803-10808. (Pubitemid 27430815)
62. Sharma, S., Miyanohara, A., and Friedmann, T. (2000). Separable mechanisms of attachment and cell uptake during retrovirus infection. J. Virol. 74, 10790-10795.
63. Skinner, A.M., O'Neill, S.L., and Kurre, P. (2009). Cellular microvesicle pathways can be targeted to transfer genetic information between non-immune cells. PLoS One. 4, e6219.
64. Stein, B.S., Gowda, S.D., Lifson, J.D., et al. (1987). pH-independent HIV entry into CD4-positive T cells via virus envelope fusion to the plasma membrane. Cell 49, 659-668.
65. Superti, F., Seganti, L., Ruggeri, F.M., et al. (1987). Entry pathway of vesicular stomatitis virus into different host cells. J. Gen. Virol. 68, 387-399. (Pubitemid 17007825)
66. Viejo-Borbolla, A., Pizzato, M., Blair, E.D., and Schulz, T.F. (2005). Insertion of targeting domains into the envelope glycoprotein of Moloney murine leukemia virus (MoMLV)-based vectors modulates the route of mCAT-1-mediated viral entry. Virus Res. 108, 45-55. (Pubitemid 40170332)
67. Voelkel, C., Galla, M., Maetzig, T., et al. (2010). Protein transduction from retroviral Gag precursors. Proc. Natl. Acad. Sci. U.S.A. 107, 7805-7810.
68. Walker, S.J., Pizzato, M., Takeuchi, Y., and Devereux, S. (2002). Heparin binds to murine leukemia virus and inhibits Envindependent attachment and infection. J. Virol. 76, 6909-6918. (Pubitemid 41246206)
69. Wei, B.L., Denton, P.W., O'Neill, E., et al. (2005). Inhibition of lysosome and proteasome function enhances human immunodeficiency virus type 1 infection. J. Virol. 79, 5705-5712. (Pubitemid 40548239)
70. Wiethoff, C.M., Wodrich, H., Gerace, L., and Nemerow, G.R. (2005). Adenovirus protein VI mediates membrane disruption following capsid disassembly. J. Virol. 79, 1992-2000. (Pubitemid 40204556)
71. Yanagi, Y., Takeda,M., andOhno, S. (2006).Measles virus: Cellular receptors, tropismand pathogenesis. J.Gen.Virol. 87, 2767-2779. (Pubitemid 44463885)
72. Yoshimori, T., Yamamoto, A., Moriyama, Y., et al. (1991). Bafilomycin A1, a specific inhibitor of vacuolar-type H+-ATPase, inhibits acidification and protein degradation in lysosomes of cultured cells. J. Biol. Chem. 266, 17707-17712. (Pubitemid 21907995)
73. Yu, Z., Beer, C., Koester, M., and Wirth, M. (2006). Caveolin-1 interacts with the Gag precursor of murine leukaemia virus and modulates virus production. Virol. J. 3, 73.
74. Zhao, Y., Zhu, L., Lee, S., et al. (1999). Identification of the block in targeted retroviral-mediated gene transfer. Proc. Natl. Acad. Sci. U.S.A. 96, 4005-4010. (Pubitemid 29169026)